These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38380611)
21. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Leppien EE; Doughty BJ; Hurd KL; Strong KN; Piper BJ; McCall KL Clin Drug Investig; 2023 Jun; 43(6):393-399. PubMed ID: 37184612 [TBL] [Abstract][Full Text] [Related]
22. A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy. Monti Guarnieri N; Pompilio A; Marini C; Ortenzi GB; Andresciani E; Garzone AMF; Ieracitano MC; Polidori C Eur J Hosp Pharm; 2023 Dec; 31(1):46-49. PubMed ID: 35410875 [TBL] [Abstract][Full Text] [Related]
23. Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients. Koristkova B; Grundmann M; Brozmanova H; Kacirova I Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):26-33. PubMed ID: 30681278 [TBL] [Abstract][Full Text] [Related]
24. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020. Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058 [TBL] [Abstract][Full Text] [Related]
25. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
26. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732 [TBL] [Abstract][Full Text] [Related]
27. Antiseizure Medication-Induced Alopecia: A Literature Review. Pitton Rissardo J; Fornari Caprara AL; Casares M; Skinner HJ; Hamid U Medicines (Basel); 2023 Jun; 10(6):. PubMed ID: 37367730 [No Abstract] [Full Text] [Related]
29. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018. Yu L; Feng J; Yu Z; Dai H Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644 [TBL] [Abstract][Full Text] [Related]
30. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase. Star K; Edwards IR; Choonara I PLoS One; 2014; 9(10):e108970. PubMed ID: 25302991 [TBL] [Abstract][Full Text] [Related]
31. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Ferrajolo C; Capuano A; Verhamme KM; Schuemie M; Rossi F; Stricker BH; Sturkenboom MC Br J Clin Pharmacol; 2010 Nov; 70(5):721-8. PubMed ID: 21039766 [TBL] [Abstract][Full Text] [Related]
32. Analyzing excipient-related adverse events in antiseizure drug formulations. Ionova Y; Peterson T; Wilson L Epilepsy Res; 2022 Aug; 184():106947. PubMed ID: 35661571 [TBL] [Abstract][Full Text] [Related]
33. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008 [TBL] [Abstract][Full Text] [Related]
34. Selection and Continuation of Antiseizure Medication in Children With Epilepsy in Sweden From 2007 to 2020. Håkansson S; Wickström R; Zelano J Pediatr Neurol; 2023 Jul; 144():19-25. PubMed ID: 37116405 [TBL] [Abstract][Full Text] [Related]
35. Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy. Tian Y; Shi Z; Cai J; Hou C; Wang X; Zhu H; Peng B; Shi K; Li X; Gong S; Chen WX BMC Pediatr; 2023 Oct; 23(1):529. PubMed ID: 37880614 [TBL] [Abstract][Full Text] [Related]
36. Priapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases. Petrović NZ; Pejčić AV; Milovanović IR Expert Opin Drug Saf; 2024 Jan; 23(1):67-78. PubMed ID: 38062555 [TBL] [Abstract][Full Text] [Related]
37. Evolution of antiseizure medication use and cost in the United States of America 2006-2021. Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279 [TBL] [Abstract][Full Text] [Related]
38. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model. Choi SA; Kim H; Kim S; Yoo S; Yi S; Jeon Y; Hwang H; Kim KJ Epilepsia; 2020 Apr; 61(4):610-616. PubMed ID: 32162687 [TBL] [Abstract][Full Text] [Related]
39. Eye disorders associated with newer antiepileptic drugs: A real-world disproportionality analysis of FDA adverse event reporting system. Hu W; Chen L; Li H; Liu J Seizure; 2022 Mar; 96():66-73. PubMed ID: 35124339 [TBL] [Abstract][Full Text] [Related]
40. Adverse reactions of Topiramate and Lamotrigine in children. Shechter T; Shorer Z; Kramer U; Lerman-Sagie T; Ronen E; Rotem R; Gorodischer R Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):187-92. PubMed ID: 15517533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]